Literature DB >> 20467412

Progress toward interruption of wild poliovirus transmission - worldwide, 2009.

.   

Abstract

In 1988, an estimated 350,000 cases of poliomyelitis were occurring annually worldwide. By 2005, because of global vaccination efforts, indigenous transmission of wild poliovirus (WPV) types 1 and 3 (WPV1 and WPV3) had been eliminated from all but four countries (Afghanistan, India, Nigeria, and Pakistan). No cases of WPV type 2 have been reported since 1999. This report describes progress toward global WPV eradication during 2009 and updates previous reports. During 2009 a total of 1,606 cases of WPV infection were reported, compared with 1,651 in 2008. WPV3 incidence increased 67%, to 1,124 cases, compared with 675 in 2008. However, WPV1 incidence decreased 51%, to 482 cases in 2009, compared with 976 cases in 2008. In India, nearly all polio cases in 2009 were reported in high-risk districts in western Uttar Pradesh and central Bihar. In Afghanistan and Pakistan, WPV circulation in high-risk districts continued because of difficulties vaccinating children in conflict-affected areas and operational limitations in parts of Pakistan. In Nigeria, cases decreased by 51%, to 388 cases in 2009, compared with 798 in 2008. During 2009, outbreaks from importation of WPV affected 19 previously polio-free African countries. Two key steps are needed to make further progress in polio eradication: 1) addressing local barriers to interrupting transmission, and 2) using bivalent oral poliovirus vaccine (bOPV) broadly for WPV 1 and 3 in supplemental immunization activities (SIAs).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20467412

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  22 in total

1.  Acute immune thrombocytopenic purpura as adverse reaction to oral polio vaccine (OPV).

Authors:  Cheng-qiang Jin; Hai-xin Dong; Zhuo-xiang Sun; Jian-wei Zhou; Cui-yun Dou; Shu-hua Lu; Rui-rui Yang
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

2.  Update on available vaccines in India: report of the APPA VU 2010: I.

Authors:  Sunil Karande
Journal:  Indian J Pediatr       Date:  2011-03-05       Impact factor: 1.967

3.  Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China.

Authors:  HaiBo Wang; Hui Cui; ZhenGrong Ding; Pian Ba; ShuangLi Zhu; Ning Wen; LiXin Hao; Jing Ning; Jie Zhang; De Yang; WenBo Xu; Yong Zhang; ChunXiang Fan; WenZhou Yu; XiaoFeng Liang; HuiMing Luo
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

4.  Resistance of polio to its eradication in Pakistan.

Authors:  Masaud Shah; Muhammad Kazim Khan; Saleha Shakeel; Faiza Mahmood; Zunaira Sher; Muhammad Bilal Sarwar; Aleena Sumrin
Journal:  Virol J       Date:  2011-10-02       Impact factor: 4.099

5.  Use of a novel real-time PCR assay to detect oral polio vaccine shedding and reversion in stool and sewage samples after a mexican national immunization day.

Authors:  Stephanie B Troy; Leticia Ferreyra-Reyes; Chunhong Huang; Nadim Mahmud; Yu-Jin Lee; Sergio Canizales-Quintero; Harry Flaster; Renata Báez-Saldaña; Lourdes García-García; Yvonne Maldonado
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

6.  The "Performance of Rotavirus and Oral Polio Vaccines in Developing Countries" (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems.

Authors:  Beth D Kirkpatrick; E Ross Colgate; Josyf C Mychaleckyj; Rashidul Haque; Dorothy M Dickson; Marya P Carmolli; Uma Nayak; Mami Taniuchi; Caitlin Naylor; Firdausi Qadri; Jennie Z Ma; Masud Alam; Mary Claire Walsh; Sean A Diehl; William A Petri
Journal:  Am J Trop Med Hyg       Date:  2015-02-23       Impact factor: 2.345

7.  Pediatric small intestine bacterial overgrowth in low-income countries.

Authors:  Jeffrey R Donowitz; William A Petri
Journal:  Trends Mol Med       Date:  2014-11-15       Impact factor: 11.951

8.  Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide Surveillance.

Authors:  James J Sejvar; Adriana S Lopez; Margaret M Cortese; Eyal Leshem; Daniel M Pastula; Lisa Miller; Carol Glaser; Anita Kambhampati; Kayoko Shioda; Negar Aliabadi; Marc Fischer; Nicole Gregoricus; Robert Lanciotti; W Allan Nix; Senthilkumar K Sakthivel; D Scott Schmid; Jane F Seward; Suxiang Tong; M Steven Oberste; Mark Pallansch; Daniel Feikin
Journal:  Clin Infect Dis       Date:  2016-06-17       Impact factor: 9.079

9.  Performance and determinants of routine immunization coverage within the context of intensive polio eradication activities in Uttar Pradesh, India: Social Mobilization Network (SM Net) and Core Group Polio Project (CGPP).

Authors:  William M Weiss; Manojkumar Choudhary; Roma Solomon
Journal:  BMC Int Health Hum Rights       Date:  2013-05-16

10.  Determinants of performance of supplemental immunization activities for polio eradication in Uttar Pradesh, India: social mobilization activities of the Social mobilization Network (SM Net) and Core Group Polio Project (CGPP).

Authors:  William M Weiss; M D Hafizur Rahman; Roma Solomon; Dora Ward
Journal:  BMC Infect Dis       Date:  2013-01-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.